Form D · Pharmaceuticals
60 Degrees Pharmaceuticals LLC
Washington, DC · CIK 0001577306
Offering snapshot reported Jun 19, 2013 · SEC filing
- Reported sold
- Yet to sell Offering amount: $10M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $100 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 19, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Debt, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $560K
- Form D file number
- 021-198274
Broker is receiving a $10,000 per month retainer for 6 months plus a 5% fee on capital raised
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| James Hawkins | 5212183 | Focus Investment Banking LLC · CRD 150589 |
| Gerald Turner | 5390257 | Focus Investment Banking LLC · CRD 150589 |
Source: Form D, filed Jun 19, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Geoffrey Stuart Dow | Executive |
| Charles Arlen Kiser, Jr. | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1025 Connecticut Avenue Nw Suite 1000
Washington, DC, 20036
Washington, DC, 20036